<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03804957</url>
  </required_header>
  <id_info>
    <org_study_id>ICH-BloodyBiopsy</org_study_id>
    <nct_id>NCT03804957</nct_id>
  </id_info>
  <brief_title>Pneumothorax After CT-guided Lung Biopsy: Standard vs Autologous Blood Patching</brief_title>
  <acronym>BloodyBiopsy</acronym>
  <official_title>The Incidence of Pneumothorax After CT-guided Lung Biopsy Performed With and Without Autologous Blood Patching: a Randomized Single-center Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Humanitas Clinical and Research Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Humanitas Clinical and Research Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this prospective, randomized study is to compare the rate of postoperative
      pneumothorax between standard CT-guided core needle biopsy (CNB) versus CNB followed by
      autologous blood patch injection (ABPI).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pneumothorax is the most common complication of percutaneous lung biopsies. Reducing this
      risk is a goal of those who perform these procedures, particularly a reduction in large
      pneumothoraces requiring intervention (eg, pleural drainage) and hospitalization (Clayton et
      al. 2016). Recently, autologous blood patch injection (ABPI) inside the biopsy track has been
      suggested as an effective mean of sealing the punctured lung thus halting air loss and
      consequently pneumothorax (Graffy et al. 2017).

      The aim of this prospective, randomized study is to compare the rate of postoperative
      pneumothorax between standard CT-guided core needle biopsy (CNB) versus CNB followed by ABPI.

      In particular, the main objectives are to compare:

        1. incidence of immediate pneumothorax

        2. incidence of late pneumothorax (2 hrs)

        3. incidence of chest tube placement

        4. duration of the procedure
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2019</start_date>
  <completion_date type="Anticipated">April 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized two arms single center</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Early Pneumothorax after biopsy</measure>
    <time_frame>Immediately after lung puncture</time_frame>
    <description>Early Pneumothorax after biopsy as seen by immediate post-biopsy CT and X-ray</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Late Pneumothorax after biopsy</measure>
    <time_frame>2-6 hours</time_frame>
    <description>Delayed Pneumothorax after biopsy as seen by X-ray after 2-6 hours</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Pneumothorax</condition>
  <condition>Biopsy Wound</condition>
  <arm_group>
    <arm_group_label>CT-guided core needle biopsy (CNB)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>18 gauge ct-guided lung biopsy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CNB followed by ABPI.</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>17 gauge coaxial needle for a 18g ct-guided lung biopsy followed by autologous blood patch injection</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Autologous blood patch injection (ABPI)</intervention_name>
    <description>Autologous blood patch injection (ABPI) through a coaxial needle at the site of biopsy</description>
    <arm_group_label>CNB followed by ABPI.</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>CT-guided core needle biopsy (CNB)</intervention_name>
    <description>Standard 18g lung core biopsy</description>
    <arm_group_label>CT-guided core needle biopsy (CNB)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        All patients scheduled for lung biopsy will be asked to join this study. After signing the
        informed consent the subject will be randomized for ABPI vs CNB approach.

        Inclusion criteria:

        1) patients with pulmonary nodule requiring CT-guided lung biopsy.

        Exclusion criteria:

          1. unfit for lung biopsy (INR &gt;1.5, PLT &lt;50.000, single lung);

          2. unavailable venous access.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>EZIO LANZA, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>HUMANITAS RESEARCH HOSPITAL</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>EZIO LANZA, MD</last_name>
    <phone>0282247383</phone>
    <email>eziolanza@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>FRANCESCA PICCOLI, MD</last_name>
    <email>francesca.piccoli3@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Humanitas Research Hospital</name>
      <address>
        <city>Rozzano</city>
        <state>Lombardia</state>
        <zip>20089</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <results_reference>
    <citation>Maybody M, Muallem N, Brown KT, Moskowitz CS, Hsu M, Zenobi CL, Jihad M, Getrajdman GI, Sofocleous CT, Erinjeri JP, Covey AM, Brody LA, Yarmohammadi H, Deipolyi AR, Bryce Y, Alago W, Siegelbaum RH, Durack JC, Gonzalez-Aguirre AJ, Ziv E, Boas FE, Solomon SB. Autologous Blood Patch Injection versus Hydrogel Plug in CT-guided Lung Biopsy: A Prospective Randomized Trial. Radiology. 2019 Feb;290(2):547-554. doi: 10.1148/radiol.2018181140. Epub 2018 Nov 27.</citation>
    <PMID>30480487</PMID>
  </results_reference>
  <results_reference>
    <citation>Graffy P, Loomis SB, Pickhardt PJ, Lubner MG, Kitchin DR, Lee FT Jr, Hinshaw JL. Pulmonary Intraparenchymal Blood Patching Decreases the Rate of Pneumothorax-Related Complications following Percutaneous CT-Guided Needle Biopsy. J Vasc Interv Radiol. 2017 Apr;28(4):608-613.e1. doi: 10.1016/j.jvir.2016.12.1217. Epub 2017 Feb 6.</citation>
    <PMID>28185770</PMID>
  </results_reference>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>December 24, 2018</study_first_submitted>
  <study_first_submitted_qc>January 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 15, 2019</study_first_posted>
  <last_update_submitted>January 11, 2019</last_update_submitted>
  <last_update_submitted_qc>January 11, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>biopsy</keyword>
  <keyword>pneumothorax</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumothorax</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

